GlassScriptPhysician profile
Neelam Gupta
NPI 1922289628
$2,551.23
in general payments reported to CMS, 2019-2025
33 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $108 · 2021: $447 · 2022: $414 · 2023: $382 · 2024: $739 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338 · Education: $90.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.84 |
| Education | $90.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.71 | 2022-2025 | |
| Redhill Biopharma INC. | $244.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $207.41 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $180.92 | 2020-2025 | Mounjaro, Emgality, Jardiance |
| Stryker Corporation | $128.53 | 2022 | |
| Glaxosmithkline, LLC. | $121.97 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.90 | 2021-2024 | Spiriva Respimat |
| Intra-Sana Laboratories | $115.13 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Harmony Biosciences LLC | $89.99 | 2024 | |
| Shield Therapeutics INC | $83.14 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $71.54 | 2020-2022 | |
| Novo Nordisk INC | $66.13 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $57.99 | 2019-2022 | |
| Pfizer INC. | $44.46 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $42.54 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $41.32 | 2019-2020 | |
| Ardelyx, INC. | $26.00 | 2025 | Ibsrela |
| Grifols USA, LLC | $25.19 | 2024 | Prolastin-C Liquid |
| Abbott Laboratories | $24.12 | 2025 | Freestyle Libre 3 |
| Genzyme Corporation | $23.92 | 2025 | |
| Viatris Specialty LLC | $22.49 | 2025 | Yupelri |
| Baxter Healthcare | $22.43 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Astellas Pharma US INC | $21.70 | 2024 | Veozah |
| Allergan, INC. | $20.16 | 2020 | |
| Idorsia Pharmaceuticals US INC | $19.84 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $19.50 | 2024 | Rexulti |
| Alkermes, INC. | $15.93 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.84 | 2025 | Caplyta |
| Scilex Pharmaceuticals INC. | $15.15 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.58 | 2019 | |
| Mylan Specialty L.P. | $12.50 | 2021 | |
| Sun Pharmaceutical Industries INC. | $12.48 | 2020 | |
| Sumitomo Pharma America, INC. | $0.79 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neelam Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.